Afatinib in first-line setting for NSCLC harbouring common EGFR mutations: New light after the preliminary results of LUX-Lung 7?

Antonio Passaro, Alessia Pochesci, Gianluca Spitaleri, Chiara Catania, Cristina Noberasco, Ester del Signore, Filippo de Marinis

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Afatinib in first-line setting for NSCLC harbouring common EGFR mutations: New light after the preliminary results of LUX-Lung 7?'. Together they form a unique fingerprint.

Medicine & Life Sciences